Clinical trial
Suramin in Treating Patients With Recurrent Primary Brain Tumors
NCT00002639 · Emory University, Other · Completed
Key facts
| NCT number | NCT00002639 |
|---|---|
| Title | Suramin in Treating Patients With Recurrent Primary Brain Tumors |
| Official title | ANALYSIS OF THE EFFICACY OF SURAMIN IN RECURRENT MALIGNANT PRIMARY BRAIN TUMORS |
| Lead sponsor | Emory University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | chemotherapy, suramin |
| Start date | Jul 1, 1995 |
| Completion | May 1, 2004 |
| First posted | May 26, 2004 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: